The global frontotemporal dementia therapeutics market is experiencing significant expansion. This trend can be attributed to a increasing prevalence of frontotemporal dementia, coupled with advancements in research and manufacture of novel therapies. The market is fueled by a blend of factors, including an aging population, increasing healthcare e